The effect of monoethylphosphate (MEP, commercial available or synthesized) together with IL-2 on the selective proliferation of human Υ δ T cells in vitro from peripheral blood mononuclear cells (PBMC) of healthy donors and of cancer patients was investigated. The Υ δ T cells were stimulated by MEP to proliferate in a dose-dependent manner. The effect of synthesized MEP was 10 times greater than that of commercial MEP. When the PBMCs of healthy donors were cultured for 25 d in the medium containing different concentrations of MEP, the total cell number increased about 1000-3000 fold; and the ratio of Υ δ T cells reached to 70-80%. The selective expansion of Υ δ T cells depended on the synergic action of MEP and IL-2. The bulk cultured Υ δ T cells exhibited obvious cytotoxic activities against allogenic tumor cell lines (SQ-5, K562 and Daudi) and autologous tumor cells. The culture system described here not only offers a simple method for obtaining a large number of Υ δ T cells which may become a new effector in the adoptive immunotherapy, but also provides a useful model for the further studies of the structure and function of Υ δ T cells in vitro .
INTRODUCTION
Although many papers have reported the diversity, development and subtype heterogeneity of Υ δ T cells, their physiological role in the immune responses remains an important and unresolved question [i-3] . However, the accumulated experimental results provided the evidences for the specific functions of Υ δ T cells in immunity against bacterial pathogen and viral infection [4] [5] [6] [7] [8] , and in the anti-tumor activity in human [9] . Furthermore, the current studies suggest that Υ δ T cells recognition may be fundamentally different from that of α β T cells [10, 11] . More importantly, the charateristics of the antigens recognized by Υ δ T cells are more clear now [12] [13] [14] [15] . The nonpeptide ligands for human peripheral blood Υ δ T cells were reported recently [5, 16] .
Υ δT cells comprise about 5% of the CD3 + T cells in human peripheral blood and lymphoid tissues [17] . Many attempts to expand these cells from the blood of healthy donors failed, because the cultures were quickly overgrown with α β T cells [l] .
In our present study, we confirmed the effect of MEP (monoethylphosphate, commercial or synthesized, which was reported as one of the nonpeptide ligands for human Υ δ T cells) on the selective proliferation of Υ δ T cells from peripheral blood mononuclear cells (PBMC) of healthy donors and cancer patients. The establishment of a culture system for the stable and optimal growth of Υ δ T cells and the cytotoxicity of the cultured Υ δ T cells against some autologous and allogenic tumor cells will be presented.
MATERIALS AND METHODS

Cell line and culture medium
The LAK-sensitive cell line Daudi, the NK-sensitive cell line K562 and the human lung squamous carcinoma cell line SQ-5 were provided by RIKEN Cell Bank. Recombinant human IL-2 was kindly provided by Dr. T. Hirakawa (Ajinomoto Co., Tokyo, Japan) or purchased from Shanghai Hua Xing High Bioteehnology Co., China. SQ-5, Daudi and K562 cells were maintained in MEM, RPMI-1640 and Ham's F12 supplemented with 10% FBS respectively at 37℃ in a humidified 5% CO 2 incubator. Medium RHAMa(+) was developed for the induction of human LAK cells in RIKEN Cell Bank [18] . It is consisted of a mixture of RPMI-1640, Ham's F-12, and MEMa at 3:1:1 by volume, supplemented with 0.02 mg/L a-tocopherol, 0.002 mg/L sodium selenite, 0.004 mg/L linoleie acid, 0.2 mg/ml cholesterol, 500 mg/ml human albumin, 0.6 mg/ml mercaptoethanol, 0.6 mg/ml ethanolamine, 5 mg/ml insulin, 5 mg/ml transferrin, and 66 mg/ml pyruvic acid.
Monoethyl phosphate (MEP)
The commercial MEP was purchased from Tokyo Kasei Co., Japan. It contained 42.5% pure monoethylphosphate. The synthesized MEP was produced and identified by the lab of Prof. Masataka Mochizuki (Kyoritsu College of pharmacy, Shibakoen, Minato-ku, Tokyo, Japan). The MEP was added according to the calculation of the pure MEP present in the commercial or synthesized preparations into mole solution.
Preparation and culture of Mononuclear cells
Heparinized venous peripheral blood samples were obtained from healthy human donors and cancer patients. Mononuclear cells (PBMC) were separated by conventional Ficoll-Hypaque density gradient centrifugation. PBMC were cultured at a concentration of 5×10 5 cells/ml in 24-well plates (Becton Dickinson). The culture medium was RHAMa(+) containing 5% autoplasma, IL-2 and MEP at indicated concentrations. The cells were cultured at 37℃ in a humidified 5% CO 2 incubator. Half of the medium was replaced with fresh medium on d 3. Subcultures were carried out every 2 d after 6 d of culture.
Flow cytometric analysis of Υ δ and α β T cells At indicated times, two colour direct immunofluorescence staining was performed on PBMC (freshly isolated or cultured) with phycoerythrin-conjugated anti-TCRα/δ-1 MAbs (Becton Dickinson) and fluorescein isothiocyanate-conjugated anti-TCRα/β-1 MAbs (Becton Dickinson). The staining procedures and the concentrations of cells and MAbs were carried out according to Becton Dickison Monoclonal Antibody Source Book. 10,000 viable cells per sample were analysed on a FACS can (Becton Dickinson) using four decade log signal amplification. All viable cells were gated by exclusion of propidium iodide (1 μg/ml). The data were analysed with Lysis II software (Becton Dickinson).
Cell-mediated cytotoxicity assay
The cytotoxicity of the cultured Υ δ T cells against K562 and Daudi were measured by LDHrelease assay in 24 h as previously described [18] . A commercially available enzymatic test kit for LDH (Kyokuto Pharmaceutical Industries, Co., Tokyo) was used. The assays were performed automatically with a laboratory processor (Biomek 1000, Beckman Instruments, Inc., USA). The cytotoxicity to SQ-5 was measured by crystal violet staining (CV) method. Briefly, SQ-5 cells were seeded into 96-well microculture plates at a density of 100 cells/well with 100 μl MEM containing 10% FBS, and were precultured at 37℃ overnight. The SQ-5 cells in 6 control wells were trypsinized for counting before addition of Υ δT cells. The viable taxget cells were counted with a hematocytometer, then an appropriate number of Υ δT cells adjusted to the desired E/T ratio were added to each well in 100 ml 5% FBS RHAMa(+) supplemented with 250 U/ml IL-2. The plates were then incubated at 37℃ for 24 h in a humidified CO 2 incubator. After incubation, the culture medium was discarded and the plates were washed twice with PBS. 200 μl fixing-solution (2% paraformaldehyde, 2% CaC1 2 ) per well was added to fix the remaining SQ-5 cells for 1 min. Then, fixing solution was discarded and 100 μl CV staining solution per well was added and stained for 30 min at room temperature. After staining, the plates was washed with water 3 times and dried overnight in air. Then, to each well 200 μl 70% methanol was added to extract the dye. After 1 minute extraction, the absorbance at 540 nm was measured.
RESULTS
Selective proliferation of Υ δ T cells of healthy donors
The freshly isolated PBMCs from healthy donors were cultured in the medium containning different concentrations of MEP. At different times, the cell concentrations and the percentages of Υ δ T cells and α β T cells were counted. Fig 1-3 showed some data from a typical donor KA. After 6 d of stimulation, the cell number ( Fig  1) and the percentage of Υ δ T cells (Fig 2A) increased in a dose-dependent manner, and the percentage of α β T (Fig 2B) cells decreased correspondingly. It indicated that 0.125 mM MEP (commercial) is sufficient to stimulate the proliferation of Υ δ T cells (Fig 1, 2) . In the culture containing 1 mM MEP (commercial), the percentage of Υ δ T cells reached 53% which was 23 times greater than that in the control culture containing 250 U/ml IL-2 but without MEP. Additionally, three representatives of the flow cytometric analysis in this experiment were shown in Fig 2C. The time course of MEP action was briefly illustrated in Fig 3. For instance, when the PBMC were cultured in the medium containing 0.1 mM sythesized MEP, the percentage of Υ δ T cells increased from 2% in freshly isolated PBMC to 54% on d 6, and to 68% on d 9 (Fig 3B) , and the percentage of αβ T cells decreased correspondingly (Fig 3C) . Furthermore, there was a correlation between the increase of the ratio of Υ δ T cells and the increase of the cumulative cell number (Fig 3A,  3B) .
In Tab In the culture containing 1 mM synthesized MEP, the cell number was 8.35×10 
Cytotoxic activities of Υ δ T cells of healthy donors against allogenic tumor cells
The cytotoxic activities of the bulk cultured Υ δ T cells of donor KA and donor CH against allogenic tumor cell lines were tested respectively. The data were shown in Fig 5. At an E/T ratio of 4, 52% of the K562 cells and 68% of the SQ-5 cells were killed by the Υ δ T cells of donor CH (Fig 5A) . The Υ δ T cells from donor KA could kill 80% of the Daudi cells and 42% of the SQ-5 cells at an E/T ratio of 3 ( Fig 5B) . 
Selective expansion of Υ δ T cells of cancer patients
With the same culture conditions, we succesfully induced the selective proliferation of Υ δ T cells from PBMCs of cancer patients. As shown in Tab 2, when the PBMCs of 7 cancer patients were cultured respectively in the medium containing 1 mM MEP (commercial) and 350U/ml IL-2 for 10-14 d, the percentages of Υ δ T cells rose to about 50-90% which were much higher than that in the control cultures (5%-30%). Moreover, the cumulative cell numbers also increased correspondingly.
For example, in the patient Kang, after 2 w culture, the percentage of Υ δ T cells rose to 93%, and the cumulative cell number increase by 100 times. 
Cytotoxicity of Υ δ T cells of the cancer patient against autologous tumor cells
We examined the cytotoxicity of the expanded Υ δ T cells from the PBMCs of cancer patient Opt against autologous endometrium carcinoma. As shown in Fig  6, after cultured in the medium containing 1 mM commercial MEP for 10 d, the percentage of Υ δ T cells reached 46.14%, and the surviving percentage of tumor cells was 23% at E/T ratio of 6. However, in the control culture, the percentage of Υ δ T cells was 14.38%, and the surviving percentage of tumor cells was 57% at E/T tatio of 6. Therefore, there was a positive correlation between the increase of Υ δ T cells and the cytotoxicity against autologous tumor cells.
DISCUSSION
With the combination of MEP and IL-2, we established this simple method for the selective expansion of human Υ δ T cells in vitro . MEP alone is insufficient to induce the selective proliferaton of Υ δ T cells and IL-2 is required for maintaining the living of Υ δ T cells in vitro (data not shown). The lower concentrations of IL-2 (200-300 U/ml) are more suitable for the growth of Υ δ T cells than the higher concentrations (500-1000 U/ml) that are usually used in LAK induction. On the other hand, even when the cultures have been induced to reach a higher percentage of Υ δT cells (about 80%), it is still necessary to include MEP in the medium, otherwise the number of Υ δ T cells will decline.
The molecular analysis of human Υ δ T cell clones demonstrated that the majority of Υ δ T cells in human peripheral blood express either V δ2 or V δ1 gene fragement [19] . The studies with specific monoclonal antibodies showed that more than 70% of the Υ δ T cells in human peripheral blood of most adults are V δ2 subset cells [20] . The expansion of V δ2 Υ δ T cells in blood is thought to be the result of exposure to foreign antigens or superantigens [17] . The Υ δ T cells stimulated by MEP expressed V Υ 2 / V δ2 receptors [16] . According to the above information, the Υ δ T cells expanded in our culture system are probably Vδ2 subset.
As for the nature of the ligands for the Vδ2 Υ δ T cells in human peripheral blood, there were several different reports. One author reported that the ligand from mycobacterium tuberculosis (strain H37Rv) lysates is of nature of carbohydrate moeities [15] . Another two groups of workers demontrated that the ligand is homologous to the proteins of GroEL heat shock protein family [13, 14] . In another laboratory, four ligands from the same strain of mycobacterium tuberculosis were isolated and partially characterized, one of the which is a 5-triphosphorylated thymidine-containing compound [5] . Y. Tanaka and S. Sano reported that synthetic alkylphophates, particularly monoethylphosphate (MEP), can mimic small natural ligands of human Υ δT cells [16] . They further reported that the natural antigens which are produced by mycobacteria and recognized by human V Υ 2 / V δ2-bearing Υ δ T cells are isopentenyl pyrophosphate derivatives [3] . In our experiment, the com-parison between two kinds of MEP (synthesized and commercial) of their effects on Υ δ T cells in 4 healthy donors (Tab 1) suggested that some modifications of the ligand in the synthesized MEP might be responsible for its increaseed efficiency in promoting Υ δ T cells proliferation, as compared to commercial MEP.
Another question is the mechanism by which the ligands activate Υ δ T cells. The natural ligands were shown to exhibit all hallmarks of bacterial superantigens defined for α β T cells [15] . Whether the synthetic ligands act in the same way or not is unknown. One explanation of the synergic action of MEP and IL-2 in our experiments is that Υ δ T cells express IL-2 receptors preferentially or the affinity of their IL-2 receptors is increased under the stimulation of MEP. However, why the unique function of Υ δ T cells has so far not been recognized? One reason is that all our present knowledge about T cell recognition and activation are derived from the studies on α β T cells [i] . Hence, more experiments are required to delineate the action of MEP, IL-2 on Υ δ T cells in detail, including the functions of the antigenpresenting cells and the other accessory cells.
In order to evaluate the functional state of the expanded Υ δ T cell in our culture system, we examined the cytotoxic activities of Υ δ T cells against three allogenic tumor cell lines (Fig 5) . Our data are consistent with the results of the other researchers [21] . Like NK cells, Υ δ T cells in human peripheral blood mediate the non-MHC-restricted cytolytic effect against many tumor cells. We succeeded in expanding the Υ δ T cells from the PBMCs of cancer patients (Tab 2), which could obviously kill the autologous tumor cells (Fig 6) and also some allogenic tumor cells (data not shown). We intend to do more experiments to get the pattern in the cytotoxic activities of Υ δT cells from different cancer patients against different allogenic tumor cells. It can be envisaged that the cultured Υ δ T cells may be a new effector for the adoptive immunotherapy of cancer.
With regard to the responsiveness of the PBMCs from different donors, besides the different intensity described in Tab 1 and 2, we observed another kind of phenomenon, which we called Υ δ T cells-primed type. When the PBMCs of the donors in this type were cultured in the medium containing IL-2 (about 300 U/ml) but without MEP, the percentage of Υ δ T cells also rose rapidly from below 5% to above 60% with the increase of the cumulative cell number in the culture (data not shown), suggesting that some prior activation in vivo exerted on the Υ δ T cells. Additionally, Υ δ T cell growth was accelerated markedly in the medium containing MEP and IL-2 in the later periods of culture (data not shown). Considering the information that most Vδ2 Υ δ T cells are positive for CD45RO [1] , a probable marker for immune memory cells, and that there are some contradictory results of the experiments in vivo in an attempt to clarify the way the immune system remembers past encounters with environmental pathogens [22] , we think that the primed V δ2 Υ δ T cells expansion in our culture system might provide a model in vitro to help the study of the mechanism of immunological memory.
